MX9704667A - 6-[triazolil[3-trifluorometil)fenil]metil]-2-quinolinonas y quinolinotionas. - Google Patents

6-[triazolil[3-trifluorometil)fenil]metil]-2-quinolinonas y quinolinotionas.

Info

Publication number
MX9704667A
MX9704667A MX9704667A MX9704667A MX9704667A MX 9704667 A MX9704667 A MX 9704667A MX 9704667 A MX9704667 A MX 9704667A MX 9704667 A MX9704667 A MX 9704667A MX 9704667 A MX9704667 A MX 9704667A
Authority
MX
Mexico
Prior art keywords
4alkyl
hydrogen
quinolinethiones
quinolinones
triazolyl
Prior art date
Application number
MX9704667A
Other languages
English (en)
Other versions
MXPA97004667A (es
Inventor
Marc Gaston Venet
Dominique Jean-Pierre Mabire
Gerard Charles Sanz
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX9704667A publication Critical patent/MX9704667A/es
Publication of MXPA97004667A publication Critical patent/MXPA97004667A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Esta invencion se refiere a compuestos de formula (I), las sales ácidas de adicion farmacéuticamente aceptables y las formas estereoquímicamente isoméricas de los mismos, en donde R1 es hidrogeno, amino o alquilo C1-4; R2 es hidrogeno, halogeno o alquilo C1-4; R3 es hidrogeno, halogeno o alquilo C1-4; Y es O o S y -X1=X2- es un radical bivalente que tiene la formula: -N=CH- (a-1) o -CH=N- (a-2); composiciones que contienen los mismos y procedimientos para preparar estos compuestos; se refiere además a su uso como medicina, en particular su uso como medicina para tratar desordenes de queratinizacion.
MXPA/A/1997/004667A 1994-12-28 1997-06-20 6-[triazolil[3-trifluorometil)fenil]metil]-2-quinolinonas y quinolinotionas MXPA97004667A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94203773 1994-12-28
EP94203773.0 1994-12-28
PCT/EP1995/005173 WO1996020200A1 (en) 1994-12-28 1995-12-21 6-[triazolyl[3-(trifluoromethyl)phenyl]methyl]-2-quinolinones and -quinolinethiones

Publications (2)

Publication Number Publication Date
MX9704667A true MX9704667A (es) 1997-09-30
MXPA97004667A MXPA97004667A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
ATE207924T1 (de) 2001-11-15
US5922734A (en) 1999-07-13
AU698199B2 (en) 1998-10-29
NZ298789A (en) 1999-07-29
WO1996020200A1 (en) 1996-07-04
CA2207268A1 (en) 1996-07-04
DE69523629T2 (de) 2002-07-18
IL116577A (en) 2000-02-29
EP0800524B1 (en) 2001-10-31
PL182956B1 (pl) 2002-05-31
CN1171789A (zh) 1998-01-28
AU4436296A (en) 1996-07-19
DE69523629D1 (de) 2001-12-06
ZA9510989B (en) 1997-06-27
JPH10511654A (ja) 1998-11-10
PL321041A1 (en) 1997-11-24
TR199501688A2 (tr) 1996-07-21
FI972794A0 (fi) 1997-06-27
TW316902B (es) 1997-10-01
MY131690A (en) 2007-08-30
PT800524E (pt) 2002-04-29
CN1085668C (zh) 2002-05-29
HRP950616A2 (en) 1997-10-31
EP0800524A1 (en) 1997-10-15
IL116577A0 (en) 1996-03-31
NO311220B1 (no) 2001-10-29
RU2165419C2 (ru) 2001-04-20
FI972794A (fi) 1997-06-27
AR002264A1 (es) 1998-03-11
NO973029D0 (no) 1997-06-27
BR9510504A (pt) 1999-06-01
DK0800524T3 (da) 2002-03-25
NO973029L (no) 1997-06-27
ES2166838T3 (es) 2002-05-01

Similar Documents

Publication Publication Date Title
GEP20033053B (en) Substituted Pyrazoles as P38 Kinase Inhibitors, Methods for their Production, Pharmaceutical Compositions Containing Them and Methods for Treatment
MY102866A (en) Amide derivatives.
AP9701041A0 (en) Pyridylpyrrole compounds.
IL108382A0 (en) Amino acid derivatives, their preparation and pharmaceutical compositions containing them
DK0804252T3 (da) Monoamin-, diamid-, thiol-holdige metalchelateringsmidler
MY127718A (en) Dolastatin 10 derivatives.
SE0202462D0 (sv) Novel use
MX9700340A (es) Agentes anti-helicobacter derivados sulfonamida de azolonas.
DE60305514D1 (de) Neue verwendung von benzothiazolderivaten
WO2000021910A3 (en) 1,2-disubstituted cyclopropanes
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
AU3582095A (en) Isothiourea derivatives as no synthase inhibitors
MY131690A (en) 6-[triazolyl[3-(trifluoromethyl) phenyl]methyl]-2- quinolinones and -quinolinethiones
HUP0104308A2 (hu) Amidino- és guanidino-azetidinon-származékok, mint triptáz inhibitorok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
HUP0402515A2 (hu) Szubsztituált új N-[4-(1H-imidazol-1-il)-2-fluor-fenil]-3-(trifluor-metil)-1H-pirazol-5-karboxamidok Xa faktor inhibitorok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
PL322872A1 (en) Novel triazolones - inhibitors of b apolipoprotein synthesis
PL326554A1 (en) Derivatives of amine and thiourea and inhibitors of nitrogen oxide synthase
PL316655A1 (en) Ester and caramate derivatives of azolones exhibiting activity in respect to helicobacter
NO973340L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
TR199902955T2 (xx) Anjiogenez inhibit�r� tiadiazolil piridazin t�revleri.
WO2002098843A3 (en) Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
IL153784A0 (en) Novel n-(2-phenyl-3-aminopropyl) naphthamides
NO973242L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
NZ512891A (en) S-oxide lipid lowering compounds
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees